Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus Infections

Pediatrics

Volumn 112, Issue 6 I, 2003, Pages 1442-1446

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; PALIVIZUMAB; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY;

CHILD; CHRONIC LUNG DISEASE; COST BENEFIT ANALYSIS; HIGH RISK POPULATION; HUMAN; INFANT; LUNG DYSPLASIA; OXYGEN THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; TREATMENT INDICATION; VIRUS INFECTION;

ANTIBODIES, MONOCLONAL; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES;

EID: 0347320936     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.112.6.1442     Document Type: Review

References (5)

1. American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Respiratory syncytial virus immune globulin intravenous: indications for use. Pediatrics. 1997;99:645-650
2. American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. Pediatrics. 1998;102:1211-1216
3. Meissner HC, Long SS, and American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Technical report: revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics. 2003;112:1447-1452
4. American Academy of Pediatrics, Committee on Infectious Diseases. Measles. In: Pickering LK, ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003:419-429
5. Gilchrist S, Torok TJ, Gary HE Jr, Alexander JP, Anderson LJ. National surveillance for respiratory syncytial virus, United States, 1985-1990. J Infect Dis. 1994;170:986-990